Cadrenal Therapeutics, Inc. SEC filings CVKD
Cadrenal Therapeutics, Inc. has 277 filings in SEC EDGAR's recent list, going back to Jul 15, 2022. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 13, 2026 | Oct 9, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 9, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 9, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 9, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 9, 2026 |
| S-8 | Employee stock plan registration | Oct 8, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 7, 2026 | Oct 7, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 29, 2026 | Sep 24, 2026 |
| S-8 | Employee stock plan registration | Sep 3, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 31, 2026 | Aug 31, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| DEFA14A | Additional proxy material | Aug 3, 2026 | — |
| ARS | Annual report to shareholders | Aug 3, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Aug 3, 2026 | Sep 24, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 21, 2026 | Jul 21, 2026 |
| EFFECT | Filing | Jul 20, 2026 | — |
| 424B3 | Prospectus | Jul 20, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2026 | Jul 14, 2026 |
| D | Filing | Jul 15, 2026 | — |
| S-3 | Shelf registration | Jul 13, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jul 10, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 1, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 29, 2026 | Jun 25, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 25, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 18, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 144 | Notice of proposed sale | Jun 15, 2026 | — |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 3, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 11, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 144 | Notice of proposed sale | May 11, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 30, 2026 | Apr 30, 2026 |
| EFFECT | Filing | Apr 29, 2026 | — |
| 424B3 | Prospectus | Apr 29, 2026 | — |
| CORRESP | Letter to the SEC | Apr 27, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2026 | — |
| S-3 | Shelf registration | Apr 21, 2026 | — |
| D | Filing | Apr 6, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
Apr 1, 2026 | Mar 31, 2026 |
| 424B5 | Prospectus supplement | Apr 1, 2026 | — |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Other events
|
Feb 24, 2026 | Feb 24, 2026 |
| 424B3 | Prospectus | Jan 2, 2026 | — |
| EFFECT | Filing | Dec 31, 2025 | — |
| D | Filing | Dec 31, 2025 | — |
| 4 | Insider transaction | Dec 31, 2025 | Dec 29, 2025 |
| UPLOAD | Letter from the SEC | Dec 31, 2025 | — |
| CORRESP | Letter to the SEC | Dec 30, 2025 | — |
| 144 | Notice of proposed sale | Dec 29, 2025 | — |
| S-1 | Registration statement | Dec 29, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 23, 2025 | Dec 23, 2025 |
| 424B5 | Prospectus supplement | Dec 23, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 16, 2025 | Dec 15, 2025 |
| 424B5 | Prospectus supplement | Dec 16, 2025 | — |
| 424B5 | Prospectus supplement | Dec 16, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Dec 11, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 2, 2025 |
| 3 | Initial insider ownership | Dec 3, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Dec 1, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 18, 2025 |
| 424B5 | Prospectus supplement | Nov 18, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 28, 2025 | Oct 24, 2025 |
| 4 | Insider transaction | Oct 28, 2025 | Oct 24, 2025 |
| 144 | Notice of proposed sale | Oct 27, 2025 | — |
| 144 | Notice of proposed sale | Oct 27, 2025 | — |
| 144 | Notice of proposed sale | Oct 24, 2025 | — |
| 144 | Notice of proposed sale | Oct 24, 2025 | — |
| 4 | Insider transaction | Oct 14, 2025 | Oct 9, 2025 |
| 4 | Insider transaction | Oct 14, 2025 | Oct 9, 2025 |
| 144 | Notice of proposed sale | Oct 14, 2025 | — |
| 144 | Notice of proposed sale | Oct 14, 2025 | — |
| 144 | Notice of proposed sale | Oct 9, 2025 | — |
| 144 | Notice of proposed sale | Oct 9, 2025 | — |
| 4 | Insider transaction | Oct 7, 2025 | Oct 6, 2025 |
| 144 | Notice of proposed sale | Oct 6, 2025 | — |
| 4 | Insider transaction | Oct 3, 2025 | Oct 2, 2025 |
| 144 | Notice of proposed sale | Oct 2, 2025 | — |
| 4 | Insider transaction | Oct 1, 2025 | Sep 29, 2025 |
| 4 | Insider transaction | Oct 1, 2025 | Sep 29, 2025 |
| 144 | Notice of proposed sale | Oct 1, 2025 | — |
| 144 | Notice of proposed sale | Oct 1, 2025 | — |
| 144 | Notice of proposed sale | Sep 29, 2025 | — |
| 144 | Notice of proposed sale | Sep 29, 2025 | — |
| 144/A | Filing | Sep 29, 2025 | — |
| 4 | Insider transaction | Sep 26, 2025 | Sep 24, 2025 |
| 4 | Insider transaction | Sep 26, 2025 | Sep 24, 2025 |
| 144 | Notice of proposed sale | Sep 25, 2025 | — |
| 144 | Notice of proposed sale | Sep 25, 2025 | — |
| 144 | Notice of proposed sale | Sep 24, 2025 | — |
| 144 | Notice of proposed sale | Sep 24, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Sep 24, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Sep 15, 2025 | Sep 12, 2025 |
| 4 | Insider transaction | Aug 29, 2025 | Aug 27, 2025 |
| 4 | Insider transaction | Aug 29, 2025 | Aug 27, 2025 |
| 144 | Notice of proposed sale | Aug 28, 2025 | — |
| 144 | Notice of proposed sale | Aug 28, 2025 | — |
| 144 | Notice of proposed sale | Aug 27, 2025 | — |
| 144/A | Filing | Aug 27, 2025 | — |
| 144 | Notice of proposed sale | Aug 27, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Aug 5, 2025 | Aug 5, 2025 |
| ARS | Annual report to shareholders | Jul 31, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Jul 31, 2025 | — |
| DEF 14A | Proxy statement | Jul 31, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 18, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Apr 17, 2025 | Apr 17, 2025 |
| 424B5 | Prospectus supplement | Apr 17, 2025 | — |
| 4/A | Ownership document | Mar 24, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 4, 2025 | Mar 3, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 7, 2025 | Feb 4, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 3 | Initial insider ownership | Feb 6, 2025 | Feb 5, 2025 |
| S-8 | Employee stock plan registration | Feb 3, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Jan 29, 2025 | — |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 15, 2025 | — |
| S-8 | Employee stock plan registration | Dec 23, 2024 | — |
| 424B5 | Prospectus supplement | Dec 20, 2024 | — |
| 424B3 | Prospectus | Nov 25, 2024 | — |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 21, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2024 | — |
| S-3 | Shelf registration | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| D | Filing | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Nov 4, 2024 | Nov 1, 2024 |
| 424B5 | Prospectus supplement | Nov 4, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2024 | Oct 24, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 4, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 25, 2024 | Sep 25, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 5, 2024 | Sep 5, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Aug 20, 2024 | Aug 19, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Aug 16, 2024 | Aug 16, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 7, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 31, 2024 | Jul 29, 2024 |
| DEFA14A | Additional proxy material | Jun 12, 2024 | — |
| ARS | Annual report to shareholders | Jun 11, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Jun 11, 2024 | Jul 29, 2024 |
| PRE 14A | Preliminary proxy statement | May 29, 2024 | May 29, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Other events
|
May 9, 2024 | May 8, 2024 |
| 4 | Insider transaction | Apr 10, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 9, 2024 | Apr 9, 2023 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 2, 2024 |
| 3 | Initial insider ownership | Apr 3, 2024 | Feb 7, 2024 |
| EFFECT | Filing | Apr 2, 2024 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Apr 2, 2024 | — |
| EFFECT | Filing | Mar 20, 2024 | — |
| CORRESP | Letter to the SEC | Mar 18, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2024 | — |
| S-8 | Employee stock plan registration | Mar 12, 2024 | — |
| S-3 | Shelf registration | Mar 12, 2024 | — |
| 8-K |
Current report
Material agreement
|
Mar 12, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2024 | Mar 11, 2024 |
| 10-K | Annual report | Mar 11, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Listing notice
|
Mar 5, 2024 | Mar 5, 2024 |
| 8-K/A |
Amended current report
Listing notice
|
Feb 15, 2024 | Sep 6, 2023 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2024 | — |
| 4 | Insider transaction | Feb 12, 2024 | Oct 23, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 12, 2024 | Feb 6, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CVKD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Ponte Vedra, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1937993
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.